Blood-Thinner Reversal Agent Works in 82% of Serious Bleeding Cases
Broader results from the ANNEXA-4 trial have confirmed that Portola Pharmaceuticals’ andexanet alfa, sold as Andexxa, can…
Bleeding
-
Blood-Thinner Reversal Agent Works in 82% of Serious Bleeding Cases
Broader results from the ANNEXA-4 trial have confirmed that Portola Pharmaceuticals’ andexanet alfa, sold as Andexxa, can... -
NOAC Bleeding No More Dangerous than Warfarin Bleeding
Bleeding associated with the newer non-vitamin K oral anticoagulants (NOACs) is not more dangerous than that associated... -
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum...
NOAC Bleeding No More Dangerous than Warfarin Bleeding
Bleeding associated with the newer non-vitamin K oral anticoagulants (NOACs) is not more dangerous than that associated…
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum…
Coagulation Factor Concentrate Superior for Trauma-Induced Coagulopathy
Coagulation factor concentrates (CFC) are more effective than fresh frozen plasma (FFP) for reversing trauma-induced coagulopathy, according…